nach oben

Erschienen in:

17.02.2022 | Original Article

Diagnostic yield of multi-gene panel for muscular dystrophies and other hereditary myopathies

verfasst von: Pablo Brea Winckler, Bruna Cristine Chwal, Marco Antonnio Rocha Dos Santos, Daniela Burguêz, Marcia Polese-Bonatto, Edmar Zanoteli, Marina Siebert, Filippo Pinto e Vairo, Márcia Lorena Fagundes Chaves, Jonas Alex Morales Saute

Erschienen in: Neurological Sciences | Ausgabe 7/2022

Einloggen, um Zugang zu erhalten

Abstract

Genetic testing is being considered the first-step in the investigation of hereditary myopathies. However, the performance of the different testing approaches is little known. The aims of the present study were to evaluate the diagnostic yield of a next-generation sequencing panel comprising 39 genes as the first-tier test for genetic myopathies diagnosis and to characterize clinical and molecular findings of families from southern Brazil. Fifty-one consecutive index cases with clinical suspicion of genetic myopathies were recruited from October 2014 to March 2018 in a cross-sectional study. The overall diagnostic yield of the next-generation sequencing panel was 52.9%, increasing to 60.8% when including cases with candidate variants. Multi-gene panel solved the diagnosis of 12/25 (48%) probands with limb-girdle muscular dystrophies, of 7/14 (50%) with congenital muscular diseases, and of 7/10 (70%) with muscular dystrophy with prominent joint contractures. The most frequent diagnosis for limb-girdle muscular dystrophies were LGMD2A/LGMD-R1-calpain3-related and LGMD2B/LGMD-R2-dysferlin-related; for congenital muscular diseases, RYR1-related-disorders; and for muscular dystrophy with prominent joint contractures, Emery-Dreifuss-muscular-dystrophy-type-1 and COL6A1-related-disorders. In summary, the customized next-generation sequencing panel when applied in the initial investigation of genetic myopathies results in high diagnostic yield, likely reducing patient’s diagnostic odyssey and providing important information for genetic counseling and participation in disease-specific clinical trials.

Nur mit Berechtigung zugänglich

Walton JN (1954) On the classification and natural history of the myopathies. Trans Am Neurol Assoc 13:19–21PubMed

Norwood FL, Harling C, Chinnery PF et al (2009) Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscleclinic population. Brain 132:3175–3186PubMedCrossRef

Amburgey K, McNamara N, Bennet LR, McCormick ME, Acsadi G, Dowling JJ (2011) Prevalence of congenital myopathies in a representativepediatric United States population. Ann Neurol 70:662–665PubMedCrossRef

Dimachkie MM, Barohn RJ (2014) Distal myopathies. Neurol Clin 32:817–842PubMedPubMedCentralCrossRef

Mah JK, Korngut L, Fiest KM, Dykeman J, Day LJ, Pringsheim T et al (2015) A systematic review and meta-analysis on the epidemiology of the muscular dystrophies. Can J Neurol Sci 43:163–177CrossRef

Cohen BH (2019) Mitochondrial and metabolic myopathies. Continuum (Minneap Minn) 25:1732–1766

Wicklund MP (2019) The limb-girdle muscular dystrophies. Continuum (Minneap Minn) 25:1599–1618

Butterfield RJ (2019) Congenital muscular dystrophy and congenital myopathy. Continuum (Minneap Minn) 25:1640–1661

Winckler PB, Da Silva AMS, Coimbra-Neto AR, Carvalho E, Cavalcanti EBU, Sobreira CFR, Marrone CD, Machado-Costa MC, Carvalho AAS, Feio RHF, Rodrigues CL, Gonçalves MVM, Tenório RB, Mendonça RH, Cotta A, Paim JFO, Costa e Silva C, de Aquino Cruz C, Bená MI, Betancur DFA, El Husny AS, de Souza ICN, Duarte RCB, Reed UC, Chaves MLF, Zanoteli E, França MC Jr, Saute JA (2019) Clinicogenetic lessons from 370 patients with autosomal recessive limb-girdle muscular dystrophy. Clin Genet 96:341–353PubMedCrossRef

10.

Mercuri E, Bönnemann CG, Muntoni F (2019) Muscular dystrophies. Lancet 394(10213):2025–2038PubMedCrossRef

11.

Jackson CE, Barohn RJ (2013) A pattern recognition approach to myopathy. Continuum (Minneap Minn) 19:1674–97

12.

Pasnoor M, Dimachkie MM (2019) Approach to muscle and neuromuscular junction disorders. Continuum (Minneap Minn) 25:1536–63

13.

Wattjes MP, Kley RA, Fischer D (2010) Neuromuscular imaging in inherited muscle diseases. Eur Radiol 20:2447–2460PubMedPubMedCentralCrossRef

14.

Pillen S, Arts IMP, Zwarts MJ (2008) Muscle ultrasound in neuromuscular disorders. Muscle Nerve 37:679–693PubMedCrossRef

15.

Nigro V, Savarese M (2016) Next-generation sequencing approaches for the diagnosis of skeletal muscle disorders. Curr Opin Neurol 29:621–627PubMedCrossRef

16.

Kress W, Rost S, Kolokotronis K, Meng G, Pluta N, Müller-Reible C (2017) The genetic approach: next-generation sequencing-based diagnosis of congenital and infantile myopathies/muscle dystrophies. Neuropediatrics 48:242–246PubMedCrossRef

17.

Magri F, Nigro V, Angelini C, Mongini T, Mora M, Moroni I et al (2017) The Italian LGMD registry: relative frequency, clinical features, and differential diagnosis. Muscle Nerve 55:55–68PubMedCrossRef

18.

Rubegni A, Malandrini A, Dosi C, Astrea G, Baldacci J, Battisti C, Bertocci G, Donati MA, Dotti MT, Federico A, Giannini F, Grosso S, Guerrini R, Lenzi S, Maioli MA, Melani F, Mercuri E, Sacchini M, Salvatore S, Siciliano G, Tolomeo D, Tonin P, Volpi N, Santorelli FM, Cassandrini D (2019) Next-generation sequencing approach to hyperCKemia: a 2-year cohort study. Neurol Genet 16(5):e352CrossRef

19.

Chakravorty S, Nallamilli BRR, Khadilkar SV, Singla MB, Bhutada A, Dastur R, Gaitonde PS, Rufibach LE, Gloster L, Hegde M (2020) Clinical and genomic evaluation of 207 genetic myopathies in the Indian subcontinent. Front Neurol 11:559327PubMedPubMedCentralCrossRef

20.

Kopanos C, Tsiolkas V, Kouris A, Chapple CE, Albarca Aguilera M, Meyer R, Massouras A (2019) VarSome: the human genomic variant search engine. Bioinformatics 35:1978–1980PubMedCrossRef

21.

Robinson JT, Thorvaldsdóttir H, Winckler W, Guttman M, Lander ES, Getz G, Mesirov JP (2011) Integrative genomics viewer. Nat Biotechnol 29:24–26PubMedPubMedCentralCrossRef

22.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, ACMG Laboratory Quality Assurance Committee (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–24PubMedPubMedCentralCrossRef

23.

Abou Tayoun AN, Pesaran T, DiStefano MT, Oza A, Rehm HL, Biesecker LG, Harrison SM, ClinGen Sequence Variant Interpretation Working Group (ClinGen SVI) (2018) Recommendations for interpreting the loss of function PVS1 ACMG/AMP variant criterion. Hum Mutat 39:1517–1524PubMedPubMedCentralCrossRef

24.

Biesecker LG, Harrison SM, ClinGen Sequence Variant Interpretation Working Group (2018) The ACMG/AMP reputable source criteria for the interpretation of sequence variants. Genet Med 20:1687–1688PubMedPubMedCentralCrossRef

25.

Brnich SE, Abou Tayoun AN, Couch FJ, Cutting GR, Greenblatt MS, Heinen CD, Kanavy DM, Luo X, McNulty SM, Starita LM, Tavtigian SV, Wright MW, Harrison SM, Biesecker LG, Berg JS, Clinical Genome Resource Sequence Variant Interpretation Working Group (2019) Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation framework. Genome Med 12:3PubMedPubMedCentralCrossRef

26.

Adzhubei IA, Schmidt S, Peshkin L et al (2010) A method and server for predicting damaging missense mutations. Nat Methods 7:248–249PubMedPubMedCentralCrossRef

27.

Ng PC, Henikoff S (2001) Predicting deleterious amino acid substitutions. Genome Res 11(5):863–874PubMedPubMedCentralCrossRef

28.

Rentzsch P, Witten D, Cooper GM, Shendure J, Kircher M (2019) CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res 47:D886–D894PubMedCrossRef

29.

Jagadeesh KA, Wenger AM, Berger MJ, Guturu H, Stenson PD, Cooper DN, Bernstein JA, Bejerano G (2016) M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity. Nat Genet 48:1581–1586PubMedCrossRef

30.

Schwarz JM, Cooper DN, Schuelke M, Seelow D (2014) MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods 11:361–362PubMedCrossRef

31.

Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnell SK, Baheti S, Musolf A, Li Q, Holzinger E, Karyadi D, Cannon-Albright LA, Teerlink CC, Stanford JL, Isaacs WB, Xu J, Cooney KA, Lange EM, Schleutker J, Carpten JD, Powell IJ, Cussenot O, Cancel-Tassin G, Giles GG, MacInnis RJ, Maier C, Hsieh CL, Wiklund F, Catalona WJ, Foulkes WD, Mandal D, Eeles RA, Kote-Jarai Z, Bustamante CD, Schaid DJ, Hastie T, Ostrander EA, Bailey-Wilson JE, Radivojac P, Thibodeau SN, Whittemore AS, Sieh W (2016) REVEL: an ensemble method for predicting the pathogenicity of rare missense variants. Am J Hum Genet 99:877–885PubMedPubMedCentralCrossRef

32.

Desmet FO, Hamroun D, Lalande M, Collod-Béroud G, Claustres M, Béroud C (2009) Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res 37:e67PubMedPubMedCentralCrossRef

33.

Cooper GM, Stone EA, Asimenos G et al (2005) Distribution and intensity of constraint in mammalian genomic sequence. Genome Res 15:901–913PubMedPubMedCentralCrossRef

34.

Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alföldi J, Wang Q, Collins RL, Laricchia KM, Ganna A, Birnbaum DP, Gauthier LD, Brand H, Solomonson M, Watts NA, Rhodes D, Singer-Berk M, England EM, Seaby EG, Kosmicki JA, Walters RK, Tashman K, Farjoun Y, Banks E, Poterba T, Wang A, Seed C, Whiffin N, Chong JX, Samocha KE, Pierce-Hoffman E, Zappala Z, O’Donnell-Luria AH, Minikel EV, Weisburd B, Lek M, Ware JS, Vittal C, Armean IM, Bergelson L, Cibulskis K, Connolly KM, Covarrubias M, Donnelly S, Ferriera S, Gabriel S, Gentry J, Gupta N, Jeandet T, Kaplan D, Llanwarne C, Munshi R, Novod S, Petrillo N, Roazen D, Ruano-Rubio V, Saltzman A, Schleicher M, Soto J, Tibbetts K, Tolonen C, Wade G, Talkowski ME, Genome Aggregation Database Consortium, Neale BM, Daly MJ, MacArthur DG (2020) The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581:434–443PubMedPubMedCentralCrossRef

35.

Fowler A, Mahamdallie S, Ruark E, Seal S, Ramsay E, Clarke M, Uddin I, Wylie H, Strydom A, Lunter G, Rahman N (2016) Accurate clinical detection of exon copy number variants in a targeted NGS panel using DECoN. Wellcome Open Res 1:20PubMedPubMedCentralCrossRef

36.

Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215PubMedPubMedCentralCrossRef

37.

Savarese M, Di Fruscio G, Torella A, Fiorillo C, Magri F, Fanin M, Ruggiero L, Ricci G, Astrea G, Passamano L, Ruggieri A, Ronchi D, Tasca G, D’Amico A, Janssens S, Farina O, Mutarelli M, Marwah VS, Garofalo A, Giugliano T, Sampaolo S, Del Vecchio BF, Esposito G, Piluso G, D’Ambrosio P, Petillo R, Musumeci O, Rodolico C, Messina S, Evilä A, Hackman P, Filosto M, Di Iorio G, Siciliano G, Mora M, Maggi L, Minetti C, Sacconi S, Santoro L, Claes K, Vercelli L, Mongini T, Ricci E, Gualandi F, Tupler R, De Bleecker J, Udd B, Toscano A, Moggio M, Pegoraro E, Bertini E, Mercuri E, Angelini C, Santorelli FM, Politano L, Bruno C, Comi GP, Nigro V (2016) The genetic basis of undiagnosed muscular dystrophies and myopathies: Results from 504 patients. Neurology 87:71–76PubMedPubMedCentralCrossRef

38.

Gonzalez-Quereda L, Rodriguez MJ, Diaz-Manera J, Alonso-Perez J, Gallardo E, Nascimento A, Ortez C, Natera-de Benito D, Olive M, Gonzalez-Mera L, Munain AL, Zulaica M, Poza JJ, Jerico I, Torne L, Riera P, Milisenda J, Sanchez A, Garrabou G, Llano I, Madruga-Garrido M, Gallano P (2020) Targeted next-generation sequencing in a large cohort of genetically undiagnosed patients with neuromuscular disorders in Spain. Genes (Basel) 11:539CrossRef

39.

Winder TL, Tan CA, Klemm S, White H, Westbrook JM, Wang JZ, Entezam A, Truty R, Nussbaum RL, McNally EM, Aradhya S (2020) Clinical utility of multigene analysis in over 25,000 patients with neuromuscular disorders. Neurol Genet 6:e412PubMedPubMedCentralCrossRef

40.

Dardas Z, Swedan S, Al-Sheikh Qassem A, Azab B (2020) The impact of exome sequencing on the diagnostic yield of muscular dystrophies in consanguineous families. Eur J Med Genet 63:103845PubMedCrossRef

41.

Magri F, Nigro V, Angelini C, Mongini T, Mora M, Moroni I, Toscano A, D’angelo MG, Tomelleri G, Siciliano G, Ricci G, Bruno C, Corti S, Musumeci O, Tasca G, Ricci E, Monforte M, Sciacco M, Fiorillo C, Gandossini S, Minetti C, Morandi L, Savarese M, Fruscio GD, Semplicini C, Pegoraro E, Govoni A, Brusa R, Del Bo R, Ronchi D, Moggio M, Bresolin N, Comi GP (2017) The Italian limb girdle muscular dystrophy registry: relative frequency, clinical features, and differential diagnosis. Muscle Nerve 55(1):55–68. https://doi.org/10.1002/mus.25192CrossRefPubMed

42.

Nallamilli BRR, Chakravorty S, Kesari A, Tanner A, Ankala A, Schneider T, da Silva C, Beadling R, Alexander JJ, Askree SH, Whitt Z, Bean L, Collins C, Khadilkar S, Gaitonde P, Dastur R, Wicklund M, Mozaffar T, Harms M, Rufibach L, Mittal P, Hegde M (2018) Genetic landscape and novel disease mechanisms from a large LGMD cohort of 4656 patients. Ann Clin Transl Neurol 5:1574–1587PubMedPubMedCentralCrossRef

43.

Passos-Bueno MR, Vainzof M, Moreira ES, Zatz M (1999) Seven autosomal recessive limb-girdle muscular dystrophies in the Brazilian population: from LGMD2A to LGMD2G. Am J Med Genet 82:392–398PubMedCrossRef

44.

Ghaoui R, Cooper ST, Lek M, Jones K, Corbett A, Reddel SW, Needham M, Liang C, Waddell LB, Nicholson G, O’Grady G, Kaur S, Ong R, Davis M, Sue CM, Laing NG, North KN, MacArthur DG, Clarke NF (2015) Use of whole-exome sequencing for diagnosis of limb-girdle muscular dystrophy: outcomes and lessons learned. JAMA Neurol 72:1424–1432PubMedCrossRef

45.

Schofield D, Alam K, Douglas L, Shrestha R, MacArthur DG, Davis M, Laing NG, Clarke NF, Burns J, Cooper ST, North KN, Sandaradura SA, O’Grady GL (2017) Cost-effectiveness of massively parallel sequencing for diagnosis of paediatric muscle diseases. NPJ Genom Med 2:4PubMedPubMedCentralCrossRef

46.

François-Heude MC, Walther-Louvier U, Espil-Taris C, Beze-Beyrie P, Rivier F, Baudou E, Uro-Coste E, Rigau V, Martin Negrier ML, Rendu J, Morales RJ, Pégeot H, Thèze C, Lacourt D, Coville AC, Cossée M, Cances C (2021) Evaluating next-generation sequencing in neuromuscular diseases with neonatal respiratory distress. Eur J Paediatr Neurol 31:78–87PubMedCrossRef

47.

Wang Y, Peng W, Guo HY, Li H, Tian J, Shi YJ, Yang X, Yang Y, Zhang WQ, Liu X, Liu GN, Deng T, Sun YM, Xing WL, Cheng J, Feng ZC (2016) Next-generation sequencing-based molecular diagnosis of neonatal hypotonia in Chinese population. Sci Rep 6:29088PubMedPubMedCentralCrossRef

48.

Heller SA, Shih R, Kalra R, Kang PB (2020) Emery-Dreifuss muscular dystrophy. Muscle Nerve 61:436–448PubMedCrossRef

49.

Zanoteli E, Soares PS, Silva AMSD, Camelo CG, Fonseca ATQSM, Albuquerque MAV, Moreno CAM, Lopes Abath Neto O, Novo Filho GM, Kulikowski LD, Reed UC (2020) Clinical features of collagen VI-related dystrophies: a large Brazilian cohort. Clin Neurol Neurosurg 192:105734PubMedCrossRef

50.

Fan Y, Liu A, Wei C, Yang H, Chang X, Wang S, Yuan Y, Bonnemann C, Wu Q, Wu X, Xiong H (2018) Genetic and clinical findings in a Chinese cohort of patients with collagen VI-related myopathies. Clin Genet 93:1159–1171PubMedCrossRef

Titel: Diagnostic yield of multi-gene panel for muscular dystrophies and other hereditary myopathies
verfasst von: Pablo Brea Winckler
Bruna Cristine Chwal
Marco Antonnio Rocha Dos Santos
Daniela Burguêz
Marcia Polese-Bonatto
Edmar Zanoteli
Marina Siebert
Filippo Pinto e Vairo
Márcia Lorena Fagundes Chaves
Jonas Alex Morales Saute
Publikationsdatum: 17.02.2022
Verlag: Springer International Publishing
Erschienen in: Neurological Sciences / Ausgabe 7/2022
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-022-05934-y

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2022

Clinical, genetic, and pathological characterization of GNE myopathy in China

Olfactory dysfunction is associated with motor function only in tremor-dominant Parkinson’s disease

Common genetic basis of ALS patients and soccer players may contribute to disease risk

Seeing double: check again! Isolated unilateral pseudoabducens palsy

Duchenne muscular dystrophy newborn screening: the first 50,000 newborns screened in Taiwan